Welcome to our dedicated page for Phase Holographic Imaging Phi news (Ticker: PHIXF), a resource for investors and traders seeking the latest updates and insights on Phase Holographic Imaging Phi stock.
Phase Holographic Imaging (PHI) delivers cutting-edge solutions in quantitative phase imaging for cellular analysis. This news hub provides investors and researchers with essential updates on PHI's advancements in non-invasive cell imaging technology and its applications in regenerative medicine.
Access official press releases covering financial results, product innovations, and strategic partnerships. Our curated collection includes regulatory milestones and scientific developments critical for evaluating PHI's market position in medical technology.
Bookmark this page for real-time updates on PHI's progress in developing instruments that enable precise cell quality assessment. Stay informed about developments shaping cell therapy research and clinical applications through verified, up-to-date information.
Phase Holographic Imaging (PHI) announced its listing on the OTCQB Venture Market in the U.S., effective August 15, 2024, under the symbol PHIXF. This move is aimed at improving accessibility and engagement with U.S. investors, leveraging existing reporting standards to meet U.S. requirements. The listing signifies PHI’s growth and commitment to the U.S. market, enhancing trading transparency and liquidity.
